Recent content by KyleLennon

  1. K

    JPMorgan Chase

    JPMorgan Chase’s combination of scale, diversification, and sound risk management seems like a simple path to competitive advantage, but few other firms have been able to execute a similar strategy. JPMorgan now benefits from a nearly unrivaled combination of scale and scope within the United...
  2. K

    Viking Therapeutics

    Viking Therapeutics (VKTX) stock shot up over 100%, despite the fact that ValueEngine downgraded the company from Strong Buy to Buy. The stock moved up in response to Madrigal Pharmaceuticals' announcement of successful 36-week results from a Phase 2 study of NonAlcoholic SteatoHepatitis...
  3. K

    Box

    Box reported better-than-expected financials and met or beat estimates on its guidance. However, it falls sharply despite earnings beat. Aaron Levie, Box CEO, pointed out to strong attach rates for new products, expansion in the international customer base and product innovation and security...
  4. K

    Momo

    After Momo reported its Q1 results, its stock price increased 11%. The company recorded a 64% year-on-year revenue growth and increased Q2 guidance from $470M to $485M. However, its mobile games revenue declined to $6.6M (-43% year-over-year because of the loss of paying users).
  5. K

    Constellation Brands

    Constellation Brands has been significantly gaining from strength in beer business over the years. Constellation Brands’ consistent focus on brand building and its initiatives to include new products are the key revenue drivers for the stock. It has been consistently generating strong cash...
  6. K

    Cara Therapeutics

    ValuEngine upgraded Cara Therapeutics (CARA). Cara is evaluating an injection of CR845 in a phase-3 clinical study targeting treatment of chronic kidney disease-associated pruritus (CKD-aP) patients. How do you think CARA?
  7. K

    Will Bitcoin continue to rise?

    Bitcoin recovered today to a price level above $7,500. The coin price dropped yesterday because of the criminal probe into whether traders are manipulating the price of Bitcoin and other digital currencies.
  8. K

    Sarepta Therapeutics is Crazy!!

    Sarepta has been pursuing strategic collaborations for the development of its disease- modifying DMD pipeline ever since it gained approval for Exondys 51. Its quarterly revenue growth was 956.60%, super awesome!! If you look at its performance, its stock price is higher and higher. Do you...
  9. K

    Fitbit vs. Xiaomi

    I do not have Xiaomi watch, but I have Xiaomi Vacuum cleanser robot, cheap and good compared to other brands.
  10. K

    How far will GoPro go?

    OK, if I dropped them...:lol:
  11. K

    How far will GoPro go?

    GoPro is taking steps to solidify its position in the burgeoning VR market. Its new VR capture rigs, Omni and Odyssey and stitching software, Kolor, all look pretty good. Do you think it will rebound?
  12. K

    Fitbit vs. Xiaomi

    Why not Xiaomi? Did you try it before?
  13. K

    Fitbit vs. Xiaomi

    After years of maintaining its leading position in the wearables market, Fitbit finally lost its ground to Xiaomi. According to the latest International Data Corporation (IDC) report, Xiaomi is tied at the top in terms of third-quarter 2017 shipment volumes, with it having shipped 3.6 million...
  14. K

    ANDV - Andeavor

    :thumbsup::thumbsup::thumbsup:
  15. K

    ANDV - Andeavor

    Andeavor, formerly known as Tesoro Corporation, or simply as Tesoro, is a Fortune 100 and a Fortune Global 500 company headquartered in Texas at San Antonio, with 2013 annual revenues of $37 billion, and over 13,000 employees worldwide. ANDV reported better than expected Q1 earnings. Revenues...
Top